The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

While melanoma is much less common than other types of skin cancer, it is the most serious because it is more likely to ...

The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...

What is viscosupplementation treatment for arthritis? During viscosupplementation treatment for arthritis, your health care provider injects hyaluronic acid into your joint. This thick fluid may help ...

[A] No treatment ... Clinically on 96 adults diagnosed with melasma randomized to three equal groups to receive one of the tested drugs applied twice daily for 4 weeks, evaluated by the response ...

Melasma is a prevalent, persistent, recurring pigment illness with a poorly understood pathophysiology that has a detrimental impact on cosmetic quality of life. Despite no curative treatment for ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Antibiotic drugs, which treat bacterial infections, are the primary form of treatment for bacterial pneumonia. Treatment is started as soon as possible, typically with oral antibiotics taken by mouth.

The US Food and Drug Administration (FDA ... healthcare providers have the freedom to further personalise treatment plans based on individual needs,” said Mr Gregory Mattingly, founding partner ...

NEW YORK – One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted ... a major gap in depression treatment,” he said.